annual EBITDA:
$1.02B+$73.08M(+7.69%)Summary
- As of today (September 17, 2025), RDY annual EBITDA is $1.02 billion, with the most recent change of +$73.08 million (+7.69%) on March 31, 2025.
- During the last 3 years, RDY annual EBITDA has risen by +$402.31 million (+64.73%).
- RDY annual EBITDA is now at all-time high.
Performance
RDY EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$252.46M+$15.75M(+6.65%)Summary
- As of today (September 17, 2025), RDY quarterly EBITDA is $252.46 million, with the most recent change of +$15.75 million (+6.65%) on June 30, 2025.
- Over the past year, RDY quarterly EBITDA has dropped by -$3.50 million (-1.37%).
- RDY quarterly EBITDA is now -1.84% below its all-time high of $257.18 million, reached on September 30, 2024.
Performance
RDY quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$746.35M-$3.50M(-0.47%)Summary
- As of today (September 17, 2025), RDY TTM EBITDA is $746.35 million, with the most recent change of -$3.50 million (-0.47%) on June 30, 2025.
- Over the past year, RDY TTM EBITDA has dropped by -$189.37 million (-20.24%).
- RDY TTM EBITDA is now -23.16% below its all-time high of $971.34 million, reached on September 30, 2024.
Performance
RDY TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RDY EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +7.7% | -1.4% | -20.2% |
3 y3 years | +64.7% | +109.3% | +20.9% |
5 y5 years | +76.6% | +71.8% | +20.2% |
RDY EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +64.7% | -1.8% | +109.3% | -23.2% | +20.9% |
5 y | 5-year | at high | +76.6% | -1.8% | +109.3% | -23.2% | +28.9% |
alltime | all time | at high | +8595.2% | -1.8% | >+9999.0% | -23.2% | +4610.7% |
RDY EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $252.46M(+6.7%) | $746.35M(-0.5%) |
Mar 2025 | $1.02B(+7.7%) | $236.71M(-8.0%) | $749.85M(-22.8%) |
Sep 2024 | - | $257.18M(+0.5%) | $971.34M(+3.8%) |
Jun 2024 | - | $255.96M(+19.1%) | $935.72M(+0.7%) |
Mar 2024 | $950.72M(+17.8%) | $214.87M(-11.7%) | $929.30M(+2.5%) |
Dec 2023 | - | $243.34M(+9.8%) | $906.89M(-0.9%) |
Sep 2023 | - | $221.55M(-11.2%) | $914.69M(-1.7%) |
Jun 2023 | - | $249.55M(+29.7%) | $930.50M(+16.1%) |
Mar 2023 | $806.96M(+29.8%) | $192.46M(-23.4%) | $801.56M(+4.8%) |
Dec 2022 | - | $251.13M(+5.8%) | $764.63M(+13.4%) |
Sep 2022 | - | $237.37M(+96.8%) | $674.49M(+9.2%) |
Jun 2022 | - | $120.61M(-22.5%) | $617.40M(-0.4%) |
Mar 2022 | $621.49M(+2.9%) | $155.53M(-3.4%) | $619.81M(+2.9%) |
Dec 2021 | - | $160.99M(-10.7%) | $602.56M(+1.3%) |
Sep 2021 | - | $180.28M(+46.6%) | $594.76M(+2.7%) |
Jun 2021 | - | $123.01M(-11.0%) | $579.16M(-4.0%) |
Mar 2021 | $603.81M(+4.1%) | $138.28M(-9.7%) | $603.12M(+1.4%) |
Dec 2020 | - | $153.18M(-7.0%) | $594.65M(+1.6%) |
Sep 2020 | - | $164.68M(+12.0%) | $585.00M(-5.8%) |
Jun 2020 | - | $146.97M(+13.2%) | $620.71M(+7.2%) |
Mar 2020 | $579.77M(+27.6%) | $129.81M(-9.6%) | $578.90M(+2.4%) |
Dec 2019 | - | $143.53M(-28.4%) | $565.36M(+5.6%) |
Sep 2019 | - | $200.39M(+90.6%) | $535.54M(+21.3%) |
Jun 2019 | - | $105.16M(-9.6%) | $441.51M(-1.9%) |
Mar 2019 | $454.29M(+27.9%) | $116.28M(+2.3%) | $449.98M(+7.3%) |
Dec 2018 | - | $113.71M(+6.9%) | $419.32M(-1.4%) |
Sep 2018 | - | $106.36M(-6.4%) | $425.39M(+0.8%) |
Jun 2018 | - | $113.63M(+32.7%) | $421.94M(+18.6%) |
Mar 2018 | $355.10M(-1.4%) | $85.62M(-28.5%) | $355.74M(+1.0%) |
Dec 2017 | - | $119.78M(+16.4%) | $352.08M(-1.6%) |
Sep 2017 | - | $102.91M(+117.0%) | $357.73M(+4.0%) |
Jun 2017 | - | $47.43M(-42.1%) | $343.93M(-2.5%) |
Mar 2017 | $360.22M(-39.6%) | $81.95M(-34.7%) | $352.79M(-8.7%) |
Dec 2016 | - | $125.44M(+40.8%) | $386.32M(-6.5%) |
Sep 2016 | - | $89.10M(+58.3%) | $413.01M(-17.1%) |
Jun 2016 | - | $56.29M(-51.3%) | $498.28M(-16.6%) |
Mar 2016 | $596.54M(+7.3%) | $115.48M(-24.1%) | $597.28M(-2.7%) |
Dec 2015 | - | $152.14M(-12.7%) | $613.97M(-0.0%) |
Sep 2015 | - | $174.37M(+12.3%) | $614.15M(+7.1%) |
Jun 2015 | - | $155.30M(+17.5%) | $573.55M(+3.4%) |
Mar 2015 | $555.71M(+7.9%) | $132.17M(-13.2%) | $554.71M(+1.6%) |
Dec 2014 | - | $152.32M(+13.9%) | $546.04M(-1.0%) |
Sep 2014 | - | $133.77M(-2.0%) | $551.43M(+0.4%) |
Jun 2014 | - | $136.45M(+10.5%) | $549.14M(+7.9%) |
Mar 2014 | $514.90M(+11.9%) | $123.50M(-21.7%) | $508.84M(-2.1%) |
Dec 2013 | - | $157.71M(+19.9%) | $519.98M(+11.2%) |
Sep 2013 | - | $131.48M(+36.7%) | $467.72M(+1.3%) |
Jun 2013 | - | $96.15M(-28.6%) | $461.94M(+1.0%) |
Mar 2013 | $459.95M | $134.64M(+27.7%) | $457.27M(+1.3%) |
Dec 2012 | - | $105.45M(-16.1%) | $451.56M(-12.4%) |
Sep 2012 | - | $125.69M(+37.4%) | $515.62M(+4.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2012 | - | $91.49M(-29.0%) | $493.52M(+1.1%) |
Mar 2012 | $495.93M(+44.1%) | $128.94M(-23.9%) | $487.96M(+7.0%) |
Dec 2011 | - | $169.51M(+63.6%) | $456.03M(+22.9%) |
Sep 2011 | - | $103.58M(+20.5%) | $371.00M(+4.4%) |
Jun 2011 | - | $85.93M(-11.4%) | $355.38M(+3.3%) |
Mar 2011 | $344.09M(+12.9%) | $97.01M(+14.8%) | $344.17M(+10.7%) |
Dec 2010 | - | $84.47M(-4.0%) | $310.79M(+1.8%) |
Sep 2010 | - | $87.96M(+17.7%) | $305.22M(+6.8%) |
Jun 2010 | - | $74.72M(+17.4%) | $285.86M(-5.0%) |
Mar 2010 | $304.89M(-3.2%) | $63.63M(-19.4%) | $300.99M(-18.1%) |
Dec 2009 | - | $78.91M(+15.0%) | $367.67M(+3.1%) |
Sep 2009 | - | $68.61M(-23.6%) | $356.48M(+5.0%) |
Jun 2009 | - | $89.85M(-31.0%) | $339.52M(+14.8%) |
Mar 2009 | $315.07M(+53.4%) | $130.31M(+92.4%) | $295.79M(+46.1%) |
Dec 2008 | - | $67.72M(+31.1%) | $202.51M(+12.6%) |
Sep 2008 | - | $51.64M(+12.0%) | $179.77M(+2.9%) |
Jun 2008 | - | $46.12M(+24.6%) | $174.65M(-7.8%) |
Mar 2008 | $205.39M(-44.0%) | $37.02M(-17.7%) | $189.38M(-33.4%) |
Dec 2007 | - | $44.98M(-3.3%) | $284.24M(-6.5%) |
Sep 2007 | - | $46.52M(-23.5%) | $303.93M(-15.1%) |
Jun 2007 | - | $60.85M(-53.9%) | $358.16M(+2.5%) |
Mar 2007 | $366.87M(+405.9%) | $131.88M(+103.9%) | $349.38M(+47.9%) |
Dec 2006 | - | $64.67M(-35.8%) | $236.26M(+27.1%) |
Sep 2006 | - | $100.76M(+93.5%) | $185.95M(+42.1%) |
Jun 2006 | - | $52.07M(+177.6%) | $130.82M(+32.1%) |
Mar 2006 | $72.52M(+118.9%) | $18.76M(+30.6%) | $99.03M(+14.6%) |
Dec 2005 | - | $14.36M(-68.5%) | $86.38M(+16.4%) |
Sep 2005 | - | $45.63M(+125.0%) | $74.22M(+100.9%) |
Jun 2005 | - | $20.28M(+232.0%) | $36.95M(+8.4%) |
Mar 2005 | $33.13M(-49.6%) | $6.11M(+177.8%) | $34.10M(+15.8%) |
Dec 2004 | - | $2.20M(-73.7%) | $29.45M(-31.7%) |
Sep 2004 | - | $8.36M(-52.0%) | $43.11M(-27.5%) |
Jun 2004 | - | $17.42M(+1090.2%) | $59.45M(-9.4%) |
Mar 2004 | $65.70M(-28.9%) | $1.46M(-90.8%) | $65.65M(-20.1%) |
Dec 2003 | - | $15.86M(-35.8%) | $82.13M(-2.5%) |
Sep 2003 | - | $24.70M(+4.5%) | $84.25M(+1.7%) |
Jun 2003 | - | $23.63M(+31.7%) | $82.83M(-8.7%) |
Mar 2003 | $92.35M(-26.2%) | $17.94M(-0.3%) | $90.75M(-5.0%) |
Dec 2002 | - | $17.99M(-22.7%) | $95.51M(-15.6%) |
Sep 2002 | - | $23.27M(-26.2%) | $113.11M(-20.0%) |
Jun 2002 | - | $31.55M(+39.0%) | $141.44M(+12.5%) |
Mar 2002 | $125.17M(+128.3%) | $22.70M(-36.2%) | $125.73M(+22.0%) |
Dec 2001 | - | $35.59M(-31.0%) | $103.03M(+52.8%) |
Sep 2001 | - | $51.60M(+225.7%) | $67.44M(+325.7%) |
Jun 2001 | - | $15.84M | $15.84M |
Mar 2001 | $54.83M(+129.1%) | - | - |
Mar 2000 | $23.93M(+30.3%) | - | - |
Mar 1999 | $18.37M(-8.7%) | - | - |
Mar 1998 | $20.13M(+71.0%) | - | - |
Mar 1997 | $11.77M(-13.1%) | - | - |
Mar 1996 | $13.55M(+3.4%) | - | - |
Mar 1995 | $13.11M | - | - |
FAQ
- What is Dr. Reddy's Laboratories Limited annual EBITDA?
- What is the all time high annual EBITDA for Dr. Reddy's Laboratories Limited?
- What is Dr. Reddy's Laboratories Limited annual EBITDA year-on-year change?
- What is Dr. Reddy's Laboratories Limited quarterly EBITDA?
- What is the all time high quarterly EBITDA for Dr. Reddy's Laboratories Limited?
- What is Dr. Reddy's Laboratories Limited quarterly EBITDA year-on-year change?
- What is Dr. Reddy's Laboratories Limited TTM EBITDA?
- What is the all time high TTM EBITDA for Dr. Reddy's Laboratories Limited?
- What is Dr. Reddy's Laboratories Limited TTM EBITDA year-on-year change?
What is Dr. Reddy's Laboratories Limited annual EBITDA?
The current annual EBITDA of RDY is $1.02B
What is the all time high annual EBITDA for Dr. Reddy's Laboratories Limited?
Dr. Reddy's Laboratories Limited all-time high annual EBITDA is $1.02B
What is Dr. Reddy's Laboratories Limited annual EBITDA year-on-year change?
Over the past year, RDY annual EBITDA has changed by +$73.08M (+7.69%)
What is Dr. Reddy's Laboratories Limited quarterly EBITDA?
The current quarterly EBITDA of RDY is $252.46M
What is the all time high quarterly EBITDA for Dr. Reddy's Laboratories Limited?
Dr. Reddy's Laboratories Limited all-time high quarterly EBITDA is $257.18M
What is Dr. Reddy's Laboratories Limited quarterly EBITDA year-on-year change?
Over the past year, RDY quarterly EBITDA has changed by -$3.50M (-1.37%)
What is Dr. Reddy's Laboratories Limited TTM EBITDA?
The current TTM EBITDA of RDY is $746.35M
What is the all time high TTM EBITDA for Dr. Reddy's Laboratories Limited?
Dr. Reddy's Laboratories Limited all-time high TTM EBITDA is $971.34M
What is Dr. Reddy's Laboratories Limited TTM EBITDA year-on-year change?
Over the past year, RDY TTM EBITDA has changed by -$189.37M (-20.24%)